Using these criteria, 54% (14/26), 12% (3/26) and 15% (3/20) of primary medulloblastomas showed evidence of overexpression of hsa-miR-30b, hsa-miR-30d, and KHDRBS3, respectively (Figure 4). The gene discussed is KHDRBS3; the disease is medulloblastoma.